Tower Research Capital (TRC)’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3K | Buy |
9,213
+5,323
| +137% | +$25K | ﹤0.01% | 3094 |
|
|
2025
Q1 | $14.2K | Buy |
3,890
+1,786
| +85% | +$6.52K | ﹤0.01% | 3308 |
|
|
2024
Q4 | $9.93K | Buy |
2,104
+683
| +48% | +$3.22K | ﹤0.01% | 3857 |
|
|
2024
Q3 | $13.2K | Sell |
1,421
-8,739
| -86% | -$81.4K | ﹤0.01% | 3533 |
|
|
2024
Q2 | $58.4K | Buy |
10,160
+9,766
| +2,479% | +$56.2K | ﹤0.01% | 2976 |
|
|
2024
Q1 | $2.64K | Sell |
394
-1,133
| -74% | -$7.6K | ﹤0.01% | 5004 |
|
|
2023
Q4 | $9.85K | Sell |
1,527
-3,394
| -69% | -$21.9K | ﹤0.01% | 4338 |
|
|
2023
Q3 | $24.6K | Buy |
4,921
+3,692
| +300% | +$18.5K | ﹤0.01% | 3191 |
|
|
2023
Q2 | $8.65K | Sell |
1,229
-1,135
| -48% | -$7.99K | ﹤0.01% | 4373 |
|
|
2023
Q1 | $15K | Buy |
2,364
+1,112
| +89% | +$7.06K | ﹤0.01% | 3781 |
|
|
2022
Q4 | $8K | Sell |
1,252
-2,435
| -66% | -$15.6K | ﹤0.01% | 4387 |
|
|
2022
Q3 | $31K | Buy |
3,687
+1,767
| +92% | +$14.9K | ﹤0.01% | 3574 |
|
|
2022
Q2 | $26K | Buy |
1,920
+1,026
| +115% | +$13.9K | ﹤0.01% | 3509 |
|
|
2022
Q1 | $14K | Sell |
894
-840
| -48% | -$13.2K | ﹤0.01% | 3884 |
|
|
2021
Q4 | $39K | Buy |
1,734
+913
| +111% | +$20.5K | ﹤0.01% | 2971 |
|
|
2021
Q3 | $11K | Sell |
821
-578
| -41% | -$7.74K | ﹤0.01% | 4218 |
|
|
2021
Q2 | $15K | Sell |
1,399
-568
| -29% | -$6.09K | ﹤0.01% | 4122 |
|
|
2021
Q1 | $26K | Buy |
1,967
+1,529
| +349% | +$20.2K | ﹤0.01% | 3678 |
|
|
2020
Q4 | $9K | Buy |
+438
| New | +$9K | ﹤0.01% | 4379 |
|